BSE filing, NSE: RADAAN. Summary written from the filing by ALFA Finder's alert engine.
Radaan Mediaworks (I) Ltd: key numbers
- Share price
- ₹2.75
- Market cap
- ₹14.89 Cr
- Revenue (annual)
- ₹5.40 Cr
- Net profit (annual)
- ₹-4.79 Cr
- P/E (TTM)
- -4.0×Sector 28.6×
- Promoter holding
- 51.42%+0.00% QoQ
- FII holding
- 0.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Radaan Mediaworks (I) Ltd
All →Radaan Mediaworks (I) Management Change
Radaan Mediaworks shareholders approved appointing Rahhul Sarath as Whole-time Director and M. Uma as Independent Director. The decisions were finalized at the company's AGM.
Radaan Mediaworks (I) Annual General Meeting
Radaan Media Works India Limited conducted its 27th Annual General Meeting on September 29, 2026. Shareholders considered the adoption of financial statements and director appointments.
Radaan Mediaworks (I) Legal & Regulatory
Radaan Mediaworks India Limited received a favorable order from CESTAT Chennai. The tribunal set aside consequential demands for interest and penalties relating to service tax appeals.
Radaan Mediaworks (I) Legal & Regulatory
CESTAT Chennai set aside a ₹5.32 Crore CENVAT credit demand against Radaan Mediaworks. The Tribunal confirmed telecast fees as eligible input services for 2012–2015.
- Value
- ₹5.32 Cr
Radaan Mediaworks (I) Annual Report
Radaan Mediaworks India Ltd filed its Annual Report for the financial year 2025-26 along with the notice for its 27th Annual General Meeting.
Radaan Mediaworks (I) Annual General Meeting
Radaan Mediaworks India Limited has scheduled its 27th Annual General Meeting for September 29, 2026. Key agenda items include adopting financial statements and appointing directors.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.